Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Bringing Genomics Home Your DNA: A Blueprint for Better Health Genome British Columbia November 18, 2015 / West Vancouver, BC Welcome and overview Our objective today is to educate and inspire you about the growing role of genomics in healthcare in BC • Dr. Brad Popovich (Genome BC) • • Dr. Joe Connors (Professor, Department of Medicine, Division of Medical Oncology, University of British Columbia and BC Cancer Agency) • • Unlocking a genetically driven disease Dr. Stuart Turvey (Professor, Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia) • • Overview of Genome BC and focus areas over the next 5 years Mystery patients: Using genomic tools to help diagnose and treat rare disease Dr. Mel Krajden (Senior Scientist, BCCDC Communicable Disease Prevention and Control Services) • Hepatitis C: 25 years from discovery to cure Genome British Columbia • A catalyst for the life sciences cluster on Canada's West Coast • Our mission is to generate social and economic benefits through genomics • Cumulative portfolio of over $710M in 254 genomics research projects and science and technology platforms • Focusing on sectors of economic importance to BC and Canada: • • • • Human health Aquaculture & Fisheries Forestry Mining, Energy & Environment • Agriculture Why genomics? What is the impact on medicine? Genomics: Provides an understanding of a disease from the inside out • • • If you understand a disease at the DNA level, you understand the root cause of the disease • Contrast this to looking at symptoms Genetic / genomic information is beneficial for disease • Diagnosis • Management • Therapeutic management • Family planning List of examples is rapidly growing First to ubiquitous 100 Years 40 Years 30 Years DNA’s Journey 1953 2000 2014 Data Source: National Human Genome Research Institute http://www.genome.gov/sequencingcosts/ Next Generation Medicine Genomic Medicine Continuum Breadth of opportunities and need to focus • • • • Disease / Condition Chronic diseases Infectious diseases Inherited conditions Health & wellness • • • • Health continuum Health & wellness Prevention & risk assessment Diagnosis Treatment & monitoring • • • • Benefits Improved health outcomes Improved healthcare system efficiency Economic growth Scientific discoveries Near term feasibility Focus areas for clinical application Long term feasibility Strategy for health research 11 Genome BC’s strategy for investment in health Progression towards benefits Health-related need Potential genomic tool / technology Validated genomic tool / technology Health benefits for BC Discovery and applied research Investment phase Translational research Pilot then population level application Genome BC focus areas Invest in genomic health research across diseases based on merit and potential impact MIND THE GAP Enable application of genomics at the level of populations Cancer, rare diseases, infectious diseases, pharmacogenomics* *Pharmacogenomics is the study of how genomic variation influences drug response (can be based on the genome of host / human, tumour, or infectious agent). Major cross-disease focus is on avoiding adverse events and optimizing dose across many diseases. 12 Prime opportunities for genomics in health in British Columbia (5 years) 1. Diseases with relatively simple genetics 2. Diseases where genomic information can influence healthcare 3. Technically and clinically feasible Cancer Rare Diseases / Rare Mutations Infectious Diseases Pharmacogenomics 13 Welcome and overview Our objective today is to educate and inspire you about the growing role of genomics in healthcare in BC • Dr. Brad Popovich (Genome BC) • • Dr. Joe Connors (Professor, Department of Medicine, Division of Medical Oncology, University of British Columbia and BC Cancer Agency) • • Unlocking a genetically driven disease Dr. Stuart Turvey (Professor, Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia) • • Overview of Genome BC and focus areas over the next 5 years Mystery patients: Using genomic tools to help diagnose and treat rare disease Dr. Mel Krajden (Senior Scientist, BCCDC Communicable Disease Prevention and Control Services) • Hepatitis C: 25 years from discovery to cure Welcome and overview Our objective today is to educate and inspire you about the growing role of genomics in healthcare in BC • Dr. Brad Popovich (Genome BC) • • Dr. Joe Connors (Professor, Department of Medicine, Division of Medical Oncology, University of British Columbia and BC Cancer Agency) • • Unlocking a genetically driven disease Dr. Stuart Turvey (Professor, Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia) • • Overview of Genome BC and focus areas over the next 5 years Mystery patients: Using genomic tools to help diagnose and treat rare disease Dr. Mel Krajden (Senior Scientist, BCCDC Communicable Disease Prevention and Control Services) • Hepatitis C: 25 years from discovery to cure Welcome and overview Our objective today is to educate and inspire you about the growing role of genomics in healthcare in BC • Dr. Brad Popovich (Genome BC) • • Dr. Joe Connors (Professor, Department of Medicine, Division of Medical Oncology, University of British Columbia and BC Cancer Agency) • • Unlocking a genetically driven disease Dr. Stuart Turvey (Professor, Division of Infectious and Immunological Diseases, Department of Pediatrics, University of British Columbia) • • Overview of Genome BC and focus areas over the next 5 years Mystery patients: Using genomic tools to help diagnose and treat rare disease Dr. Mel Krajden (Senior Scientist, BCCDC Communicable Disease Prevention and Control Services) • Hepatitis C: 25 years from discovery to cure